ArticleIn vivo (Athens, Greece)

Pathologic Complete Response After Enfortumab Vedotin Plus Pembrolizumab in Node-positive Upper Tract Urothelial Carcinoma.

Kayo Kikuchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.